Mumbai: Tata Memorial Hospital (TMH) has started a clinical trial using technology to minimise hair loss due to chemotherapy in cancer patients. The trial is being led by Dr Jyoti Bajpai, associate professor, medical oncology, TMH.
The trial, which involves four breast cancer patients initially, uses a scalp cooling technique to restrict chemotherapy medication from reaching the scalp, thus reducing hair fall. The technique is widely used in the UK, reports The Hindu.
“Through the trial, we are aiming at 50 to 70 per cent hair preservation,” said Dr Bajpai. “The most common side-effects of using scalp coolers are headache and cold, but so far, none of the participants have reported these to be unbearable.”